Corporate Partnership Programme
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
EMBL boasts some of the best scientific talent in Europe. Get in touch.
The European Molecular Biology Laboratory employs some of the greatest minds in European science. Our talent pool boasts biologists, engineers, IT professionals and countless other scientific specialisations. In addition, EMBL research has many practical and industrial applications
We harness EMBL’s entrepreneurial spirit through technology transfer programmes and technology spin-offs.
EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) is an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). Established in 1999, EMBLEM identifies, protects and commercialises the intellectual property developed at EMBL, by EMBL alumni and by non-EMBL third parties. EMBLEM works closely with industrial partners in the biotech, IT and engineering markets to accelerate the transfer of innovative technology from basic research to industry.
EMBLEM manages a portfolio of close to 300 individual patents, patent applications, copyrights, trademarks and utility models. The technology portfolio, which spans the life sciences, includes enabling technologies, scientific instruments, molecular tools and techniques, as well as software programmes and databases.
The Programme is designed to form and cultivate long-term, fruitful relationships between EMBL and top-class corporate partners.
A forum for interaction and knowledge exchange for those employed at the forefront of industrial bioinformatics.
A freely-available, large-scale, multi-year, public-private partnership that uses human genetics and genomics data for systematic drug target identification and prioritisation.
The Agri-Tech Partnership establishes collaboration with domain experts in advanced agricultural technologies from both public and private sectors.
Based in Heidelberg, Germany, EMBL Ventures invest throughout Europe to build companies that create significant commercial opportunities based on new therapeutic-treatment modalities and pharmaceuticals, next-generation enabling-technology platforms or innovations in the diagnostics and medical device area.
As an independent and focused team, EMBL Ventures moves quickly with short decision timelines.
Industry news from EMBL’s six sites
MRC and Europe PMC develop interactive dashboard to track health research funding in the UK.
Edit
EMBL Grenoble’s new Head of Administration brings industry experience to support an environment where science can thrive
Edit
Daniel Santos-Oliván, Computational Scientist in the Torres-Sánchez group at EMBL Barcelona, talks about bringing the tools of theoretical physics to biology and how artificial intelligence is reshapi…
EditAt EMBL, our vision is to create a more inclusive research and work culture that leverages diversity, in its broadest sense to enhance our role as a leader in the life sciences in Europe and globally. Joining the Human Resources team in Heidelberg, you will have the opportunity to support scientists...
Closes on 19th October. Posted 21st September 2026
EditWe have recently started an exciting ERP transformation programme and are replacing our existing HR, Finance and Procurement system landscape across all of our six sites with Workday. We have gone live with Workday HCM (Human Capital Management) in 2025 and are now in the next phase of the transform...
Closes on 1st November. Posted 21st September 2026
EditAbout the teamWe are seeking a skilled and highly motivated Bioinformatics Developer to join the Human Genomics Team at EMBL-EBI and contribute to the maintenance and development of the DECIPHER platform. DECIPHER is a global data sharing platform that fuels rare disease discovery and enables patien...
Closes on 9th October. Posted 17th September 2026
EditWith support from more than 30 countries, laboratories at six sites across Europe and thousands of scientists and engineers working together, the European Molecular Biology Laboratory (EMBL) is a powerhouse of biological expertise. EMBL is an intergovernmental organisation, headquartered in Heidelberg, and was founded in 1974 with the mission of promoting molecular biology research in Europe, training young scientists, and developing new technologies.
EMBL currently employs more than 1800 people in Barcelona, Grenoble, Hamburg, Heidelberg, EMBL-EBI Hinxton (near Cambridge), and Rome.
Publishing hundreds of research articles and hosting dozens of conferences every year, EMBL is driving visionary fundamental research and training Europe’s future scientific talent.